Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
MLH1 Gene Deletion+Duplication clinical trials
1 of 1 indexed MLH1 Gene Deletion+Duplication trials are currently recruiting.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count
MLH1 Gene Deletion+Duplication: 1 US clinical trial tracked, 1 recruiting.
MLH1 Gene Deletion+Duplication is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is San Raffaele University, running 1 of these trials.
Enrollment posture brief
Registry condition mlh1-gene-deletionduplication
OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
MLH1 Gene Deletion+Duplication lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for MLH1 Gene Deletion+Duplication on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
MLH1 Gene Deletion+Duplication is recruiting above its size-band peers.
1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
1 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on MLH1 Gene Deletion+Duplication records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on MLH1 Gene Deletion+Duplication trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this MLH1 Gene Deletion+Duplication page
1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 MLH1 Gene Deletion+Duplication trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- San Raffaele University sponsors the most MLH1 Gene Deletion+Duplication trials on record, review their full trial history before evaluating a specific study. See San Raffaele University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This MLH1 Gene Deletion+Duplication condition card totals 1 registered trials; most-linked intervention LYNX EYE (Lynch syndrome X-Talk of Enteral mucosa with Immune System); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.